Ellington Management Group’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$349K Hold
35,000
0.05% 143
2021
Q1
$347K Buy
+35,000
New +$355K 0.04% 129

Other funds holding EQHA.U

Ellington Management Group's EQHA.U Position: Q2 2021 in Review

Ellington Management Group held its EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) position steady in Q2 2021 at 35,000 shares worth $349K. The position accounts for 0.05% of the portfolio, ranked #143.

Ellington Management Group first reported a position in EQHA.U in Q1 2021 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold EQHA.U as of Q2 2021.

  • Ellington Management Group held 35,000 shares of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant worth $349K as of Q2 2021.
  • Ellington Management Group left its EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant share count unchanged in Q2 2021.
  • EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant made up 0.05% of Ellington Management Group's portfolio in Q2 2021, its #143 holding.
  • Ellington Management Group first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q2 2021.

Based on Ellington Management Group's 13F filing for Q2 2021, filed 16 Aug 2021.